E-health in inflammatory bowel diseases: More challenges than opportunities?

被引：27
作者：
Bossuyt, Peter [1 ]
Pouillon, Lieven [2 ]
Bonnaud, Guillaume [3 ]
Danese, Silvio [4 ,5 ]
Peyrin-Biroulet, Laurent [6 ,7 ]
机构：
[1] Imelda Gen Hosp Bonheiden, Imelda GI Clin Res Ctr, Bonheiden, Belgium
[2] Univ Hosp Gasthuisberg Leuven, Dept Hepatogastroenterol, Leuven, Belgium
[3] Ambroise Pare Clin, Dept Hepatogastroenterol, Toulouse, France
[4] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[5] Humanitas Clin & Res Ctr, Dept Gastroenterol, IBD Ctr, Milan, Italy
[6] Univ Lorraine, Nancy Univ Hosp, INSERM, U954, Vandoeuvre Les Nancy, France
[7] Univ Lorraine, Nancy Univ Hosp, Dept Gastroenterol, Vandoeuvre Les Nancy, France
来源：
DIGESTIVE AND LIVER DISEASE | 2017年 / 49卷 / 12期
关键词：
Crohn's disease; Disease monitoring; Mobile applications; Self management; Telemedicine; Ulcerative colitis; RANDOMIZED CONTROLLED-TRIAL; ULCERATIVE-COLITIS; SOCIAL MEDIA; FECAL CALPROTECTIN; MOBILE PHONE; IBD-LIVE; CARE; TELEMEDICINE; INTERVENTION; TECHNOLOGIES;
D O I：
10.1016/j.dld.2017.08.026
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Patients with inflammatory bowel disease need close monitoring for an optimal disease management. For this, e-health technologies are promising tools. But the current evidence for the implementation of e-health in inflammatory bowel disease is weak. For this a critical evaluation of the existing evidence is presented. Furthermore some essential conditions need to be full-filled. We need a robust digital infrastructure that is workable for the patient and the healthcare provider. Important legal issues need to be solved to protect the patient. And the e-health technologies will have to proof their durability, feasibility and acceptance for the patient on the long term. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：1320 / 1326
页数：7
相关论文
共 52 条
[1]   Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (mERA) checklist [J].
Agarwal, Smisha ;
LeFevre, Amnesty E. ;
Lee, Jaime ;
L'Engle, Kelly ;
Mehl, Garrett ;
Sinha, Chaitali ;
Labrique, Alain .
BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
[2]   Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation [J].
Akobeng, Anthony K. ;
O'Leary, Neil ;
Vail, Andy ;
Brown, Nailah ;
Widiatmoko, Dono ;
Fagbemi, Andrew ;
Thomas, Adrian G. .
EBIOMEDICINE, 2015, 2 (09) :1251-1256
[3]  
[Anonymous], 2016, EIBD PROGRAM
[4]  
[Anonymous], 2015, FDA PERMITS MARKETIN
[5]  
[Anonymous], 2016, 3 TECHNOLOGY REVOLUT
[6]   Type 1 diabetes [J].
Atkinson, Mark A. ;
Eisenbarth, George S. ;
Michels, Aaron W. .
LANCET, 2014, 383 (9911) :69-82
[7]   Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial [J].
Atreja, Ashish ;
Khan, Sameer ;
Rogers, Jason D. ;
Otobo, Emamuzo ;
Patel, Nishant P. ;
Ullman, Thomas ;
Colombel, Jean Fred ;
Moore, Shirley ;
Sands, Bruce E. .
JMIR RESEARCH PROTOCOLS, 2015, 4 (01)
[8]   The feasibility of measuring and monitoring social determinants of health and the relevance for policy and programme - a qualitative assessment of four countries [J].
Blas, Erik ;
Ataguba, John E. ;
Huda, Tanvir M. ;
Bao, Giang Kim ;
Rasella, Davide ;
Gerecke, Megan R. .
GLOBAL HEALTH ACTION, 2016, 9
[9]   Treat to Target in Inflammatory Bowel Disease [J].
Peter Bossuyt ;
Séverine Vermeire .
Current Treatment Options in Gastroenterology, 2016, 14 (1) :61-72
[10]   Efficacy of a "contact center-based communication" in optimizing the care of inflammatory bowel diseases [J].
Castiglione, Fabiana ;
Imperatore, Nicola ;
Testa, Anna ;
Rea, Matilde ;
Nardone, Olga Maria ;
Gervetti, Paola ;
Taranto, Maria Laura ;
D'Onofrio, Gaetano ;
Caporaso, Nicola ;
Rispo, Antonio .
DIGESTIVE AND LIVER DISEASE, 2016, 48 (08) :869-873
123456